Method for extracting a macrolide from biomatter

Details Method for extracting a macrolide from biomatter Method for extracting a macrolide from biomatter

2004-05-12

2008-11-18

Naff, David M. (Department: 1651)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

C435S132000, C435S169000, C435S252100, C435S253500, C435S898000

Reexamination Certificate

active

07452692

ABSTRACT:
Provided is a method for obtaining a macrolide, especially tacrolimus, ascomycin, pimecrolimus, sirolimus, or everolimus, from biomatter.

REFERENCES:
patent: 3993749 (1976-11-01), Sehgal et al.
patent: 4160861 (1979-07-01), Cole et al.
patent: 4477682 (1984-10-01), Tomita et al.
patent: 4894366 (1990-01-01), Okuhara et al.
patent: 5091389 (1992-02-01), Ondeyka et al.
patent: 5116756 (1992-05-01), Dumont et al.
patent: 5194378 (1993-03-01), Salituro et al.
patent: 5200505 (1993-04-01), Takesako et al.
patent: 5264355 (1993-11-01), Shaifee et al.
patent: 5494820 (1996-02-01), Cullen et al.
patent: 5496727 (1996-03-01), Okuhara et al.
patent: 5506233 (1996-04-01), Hauske et al.
patent: 5508398 (1996-04-01), Gletsos
patent: 5612316 (1997-03-01), Koch
patent: 5616595 (1997-04-01), Chu et al.
patent: 5622866 (1997-04-01), Motamedi et al.
patent: 5624842 (1997-04-01), Okuhara et al.
patent: 6387258 (2002-05-01), Keri et al.
patent: 6919317 (2005-07-01), Ryder et al.
patent: 2002/0010328 (2002-01-01), Reeves et al.
patent: 2002/0128470 (2002-09-01), Fuenfschilling et al.
patent: 2003/0166924 (2003-09-01), Keri et al.
patent: 2004/0050782 (2004-03-01), Fuenfschilling et al.
patent: 692 839 (2002-11-01), None
patent: 2121517 (1972-11-01), None
patent: 0 184 162 (1986-06-01), None
patent: 0 652 219 (1995-05-01), None
patent: 1 234 833 (2002-08-01), None
patent: 2 225 576 (1990-06-01), None
patent: 4128289 (1992-04-01), None
patent: WO 92/18506 (1992-10-01), None
patent: WO 00/33878 (2000-06-01), None
patent: WO-00/71546 (2000-11-01), None
patent: WO-01/18007 (2001-03-01), None
Surjit S. Sengha, Fermentation, in Kirk Othmer Encyclopedia of Chemical Technology, vol. 10, p. 361-381 (Jacquiline I. Kroschwitz, editor. 4th ed. 1993).
The Merck Index, Maryadele J. O'Neil et al. eds., “Pimecrolimus”, p. 1331, 13th ed. 2001.
Martindale: The complete drug reference, Sean C. Sweetman ed., “Sirolimus”, p. 568, Pharmaceutical Press 33rd ed. 2002.
C.E.M. Griffiths “Ascomycin: An Advance in the Management of Atopic Dermatitis” British J. of Dermatology, V. 144, p. 679-681, (2001).
Martindale: The complete drug reference, Sean C. Sweetman ed., “Everolimus”, p. 539, Pharmaceutical Press 33rd ed. 2002.
Zhiguo Song et al. “Highly Chemoselective Trichloracetimidate-Mediated Alkylation of Ascomycin: A Convergent, Practical Synthesis of the Immunosupporessant L-733,725” J. Org. Chem. 1999, v. 64, p. 1859-1867.
Jun'ichi Kobayashi et al. “Amphidinolides T2, T3, and T4, New 19-Membered Macrolides from the DinoflagellateAmphidiniumsp. and the Biosynthesis of Amphidinolide T1” J. Org. Chem. 2001, v. 66, p. 134-142.
K. Yoshii et al. “Liquid Chromatographic Determination of Emamectin, Milbemectin, Ivermectin and Abamectin in Crops and Confirmation by Liquid Chromatography—Mass Spectrometry” Journal of Chromatography A, v. 896, 2000, p. 75-85.
Patent Abstract of Japan Publication No. 02016662; Publication date Jan. 19, 1990; Akashi Kazuya “Substituting Terminal Controller”.
Arndt, Cristl, et al., “Secretion of FK506/FK520 and rapamycin byStreptomycesinhibits the growth of competingSaccharomyces cerevisiaeandCryptococcus neoformans”, Microbiology, 1999, vol. 145, pp. 1989-2000.
Akashi, Takeshi, et al., “Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography”, Journal of Pharmaceutical and Biomedical Analysis, 1996, vol. 14, pp. 339-346.
Volosov, Andrew, et al., “Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography—tandem mass-spectrometry”, Clinical Biochemistry, 2001, vol. 34, pp. 285-290.
Venkataramanan, Raman, et al., “Clinical Utility of Monitoring Tacrolimus Blood Concentrations in Liver Transplant Patients”, Journal of Clinical Pharmacology, 2001, vol. 41, pp. 542-551.
Motamedi, Haideh, et al., “Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506”, European Journal of Biochemistry, Feb. 1997, vol. 244, No. 1, pp. 74-80.
Motamedi, Haideh, et al., “The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506”, European Journal of Biochemistry, 1998, vol. 256, pp. 528-5343.
Aichi, Ken, et a., “Studies on the Development of Tacrolimus Production”, Seibutsu Kogaku Kaishi, 1998, vol. 76, No. 9, pp. 389-397.
Shafiee, Ali, et al., “Enzymology of FK506 biosynthesis: Purification and characterization of 31-O-desmethylFK-506O: methyltransferase fromStreptomycessp. MA6858”, European Journal of Biochemistry, Oct. 1994, Vo. 225, No. 2, pp. 755-764.
Motamedi, Haideh, et al., “Characterization of Methyltransferase and Hydroxylase Genes Involved in the Biosynthesis of the Immunosuppressants FK506 and FK520”, Journal of Bacteriology, Sep. 1996, vol. 178, No. 17, pp. 5243-5248.
Schwecke, Torsten, et al., “The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin”, Proc. Natl. Acad. Sci. USA, Aug. 1995, vol. 95, pp. 7839-7843.
Wu, Kai, et al., “The FK520 gene cluster ofStreptomyces hygroscopicusvar.ascomyceticus(ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units”, Gene, 2000, vol. 251, pp. 81-90.
Kino, Toru, et al., “FK-506, A novel Immunosuppressant Isolated From AStreptomyces: I. Fermentation, Isolation, and Physico-Chemical and Biological Characteristics”, The Journal of Antibiotics, vol. XL, No. 9, pp. 1249-1255.
Yoon, Yeo Joon, et al., “Nutrient Effects on FK-506, a New Immunosuppressant, Production byStreptomycessp. in a Defined Medium”, Journal of Fermentation and Bioengineering, 1997, vol. 83, No. 6, pp. 599-603.
Takeuchi, Miwako, et al., “Ring-closing metathesis protocol for a diastereocontrolled preparation of the C28-C34segment of FK-506”, Tetrahedron: Asymmetry, 2000, vol. 11, pp. 1601-1606.
Namyslo, Jan-Christoph, et al., “An Aldol Approach to a Building Block corresponding to the C21-C26-Part of FK506”, J. Prakt. Chem., 1999, vol. 341, No. 6, pp. 557-561.
Baker, Robert K., et al., “Synthetic Studies on the Immunosuppressive Agent FK-506: Enantioselective Synthesis of a C22-C34 Fragment”, Tetrahedron Letters, 1998, vol. 39, pp. 229-232.
Morimoto, Yoshiki, et al., “A Synthesis of C1-C22 Fragment of the Immunosuppressant FK506. Stereoselective Construction of (E)-Trisubstituted Double Bond (C19-C20) via Ester-enolate Claisen Rearrangement”, Tetrahedron Letters, 1991, vol. 32, No. 25, pp. 2909-2912.
Marshall, James A., et al., “Synthesis of a C22-34 Subunit of the Immunosuppressant FK-506”, Journal of Organic Chemistry, 1996, vol. 60, pp. 7230-7237.
Ireland, Robert E., et al., “A Total Synthesis of FK-506”, Journal of Organic Chemistry, 1996, vol. 61, pp. 6856-6872.
Ireland, Robert E., et al., “Total Synthesis of FK-506. Part 1: Construction of the C16-C34 Fragment”, Tetrahedron, 1997, vol. 53, No. 39, pp. 13221-13256.
Ireland, Robert E., et al., “Total Synthesis of FK-506. Part 2. Completion of the Synthesis”, Tetrahedron, 1997, vol. 53, No. 39, pp. 13257-13284.
Smith, Amos B., et al., “Formal Total Synthesis of FK506. Concise Construction of the C(10)-C(34) Segment Via an Effective Coupling Tactic”, Tetrahedron Letters, 1994, vol. 35, No. 25, pp. 4271-4274.
Nakatsuka, Masashi, et al., “Total Synthesis of FK506 and an FKBP Probe Reagent, (C8, C9-13C2)-FK506”, Journal of the American Chemical Society, 1990, vol. 112, pp. 5583-5601.
Jones, Todd K., et al., “Total Synthesis of the Immunosuppressant (-)-FK-506”, Journal of the American Chemical Society, 1989, vol. 111, pp. 1157-1159.
Aceto Pharma GmbH letter to European Patent Office, “‘Observations by Third Party’ in accordance with Art. 115 EPC regarding European

Affiliated with

Also associated with

Rating

Method for extracting a macrolide from biomatter does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for extracting a macrolide from biomatter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for extracting a macrolide from biomatter will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4039025